Whether you are looking to support your energy, your immune system, or your long-term cellular health, we are here to help you navigate the world of supplementation with science-backed information
Retatrutide is not FDA-approved and is available only for research purposes
Patients with hypermobility EDS have an increased risk of developing inflammatory diseases, including celiac disease 54 and eosinophilic esophagitis, 53 compared to the general population and also have an increased prevalence of autoantibodies, including antinuclear and antiphospholipid antibodies
Benzene-1,3,5-tricarboxylate (BTC), glutaraldehyde (GA), anhydrous ethanol, phosphate buffer solution (PBS), sodium chloride (NaCl), and peptide SP94 (SFSIIHTPILPL) were purchased from Sangon Biotech (Shanghai, China)